Skip to main content
. 2020 Dec 29;83(3):254–264. doi: 10.1055/s-0040-1716671

Table 3. Differences between approaches.

Factors Supraorbital Transnasal p -Value
n 20 11
Mean age (y) 60.7 56.0 0.382
BMI (kg/m 2 ) 30.5 34.2 0.299
Female gender (%) 15 (75%) 7 (64%) 0.505
Pre-op tumor volume (cm 3 ) 8.0 7.4 0.871
Pre-op visual acuity deficit 12 (63%) 7 (64%) 0.713
Pre-op anopsia 13 (68%) 7 (64%) 0.930
Pre-op anosmia 4 /16(25%) 1/3 (33%) N/A
Pre-op FLAIR change 7 (35%) 2 (18%) 0.429
No lateral or superior extension from CN II 9 6
Lateral extension from CN II 2 2
Superior extension from CN II 5 3
Lateral and superior extension from CN II 4 0
Anticonvulsant use 12 (60%) 2 (18%) 0.057
Lumbar drain use 0 (0%) 8 (73%) <0.0001
Post-op tumor volume (cm 3 ) 0.2017 3.2 0.0439
Extent of resection (%) 88.1% 57.9% 0.016
Post-op visual acuity deficit 2 (10%) 6 (54%) 0.004
Post-op anopsia 4 (20%) 6 (54%) 0.011
Post-op anosmia 4/14 (29%) 1/3 (33%) N/A
Post-op seizure 3 (15%) 0 (0%) 0.177
Post-op radiographic stroke 3 (15%) 0 (0%) 0.535
CSF leak 0 (0%) 2 (18%) 0.118
Post-op FLAIR change 7 (35%) 4 (36%) 1.000
Post-op DWI signal 7 (35%) 0 (0%) 0.033
Length of stay (d) 3.4 6.1 <0.001
Subsequent surgery for recurrence 4 (20%) 2 (18%) 1.000
Post-op radiation 6 (30%) 2 (18%) 0.676

Abbreviations: BMI, body mass index; CN, cranial nerve; CSF, cerebrospinal fluid; DWI, diffusion-weighted imaging; FLAIR, fluid-attenuated inversion recovery; N/A, not available; Post-op, postoperative; Pre-op, preoperative.